[SLRX] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
12-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 3.76%
YoY- 34.67%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 0 0 0 1,378 875 251 414 -
PBT -2,443 -14,409 -3,737 -1,717 -2,630 -2,638 -9,332 -20.00%
Tax -89 -78 -10 -42 -2 0 0 -
NP -2,443 -14,331 -3,737 -1,717 -2,628 -2,638 -9,332 -20.00%
Tax Rate - - - - - - - -
Total Cost 2,443 14,331 3,737 3,095 3,503 2,889 9,746 -20.58%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 0.00 0.00 0.00 -124.55 -300.33 -1,051.18 -2,256.31 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.65 -6.38 -2.09 -2.39 -18.22 -91.27 -335.48 -64.67%
EPS Diluted -0.65 -6.38 -2.09 -2.39 -18.22 -91.27 -335.48 -64.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.